| Predicate |
Object |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-7053
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-7061
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-7069
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J1-0096 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-565 |
| filingDate |
1996-07-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate |
1999-08-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-H11509222-A |
| titleOfInvention |
Agent for transdermal administration comprising an ester of 13-ethyl-17β-hydroxy-11-methylene-18,19-dinor-17α-pregn-4-en-20-yn-3-one |
| abstract |
(57) [Summary]nAn ester of 13-ethyl-17β-hydroxy-11-methylene-18,19-dinor-17α-pregn-4-en-20-yn-3-one having 1 to 20 carbon atoms in the ester group can be optionally substituted. Describes an agent for transdermal administration, characterized in that it comprises one or two estrogens in combination. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-4716726-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2005533036-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2005532350-A |
| priorityDate |
1995-07-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |